[Federal Register Volume 60, Number 128 (Wednesday, July 5, 1995)]
[Notices]
[Pages 35050-35052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-16321]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration
[DEA No. 132F]


1995 Revised Aggregate Production Quotas for Controlled 
Substances in Schedules I and II

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Notice of final revised aggregate production quotas for 1995.

-----------------------------------------------------------------------

SUMMARY: This notice establishes revised 1995 aggregate production 
quotas for controlled substances in Schedules I and II of the 
Controlled Substances Act (CSA).

DATES: This order is effective on July 5, 1995.

FOR FURTHER INFORMATION CONTACT: Howard McClain, Jr., Chief, Drug and 
Chemical Evaluation Section, Drug Enforcement Administration, 
Washington, D.C. 20537, Telephone: (202) 307-7183.

SUPPLEMENTARY INFORMATION: Section 306 of the CSA (21 U.S.C. 826) 
requires the Attorney General to establish aggregate production quotas 
for controlled substances in Schedules I and II each year. This 
responsibility has been delegated to the Administrator of the DEA 
pursuant to Section 0.100 of Title 28 of the Code of Federal 
Regulations. The Administrator, in turn, has redelegated this function 
to the Deputy Administrator of the DEA pursuant to Section 0.104 of 
Title 28 of the Code of Federal Regulations.
    On May 9, 1995, a notice of the proposed revised 1995 aggregate 
production quotas for controlled substances in Schedules I and II was 
published in the Federal Register (60 FR 24649). All interested parties 
were invited to comment on or object to these proposed aggregate 
production quotas on or before June 9, 1995.
    Several companies commented that the revised 1995 aggregate 
production quotas for amphetamine, diphenoxylate, fentanyl, 
hydrocodone, hydromorphone, methadone, methadone intermediate (for 
conversion), methylphenidate, morphine and oxycodone (for sale), were 
insufficient to provide for the estimated medical, scientific, research 
and industrial needs of the United States, for export requirements and 
for the establishment and maintenance of reserve stocks.
    The DEA has reviewed the involved companies' 1994 year-end 
inventories, their initial 1995 manufacturing quotas, 1995 export 
requirements and their actual and projected 1995 sales. Based on this 
data, the DEA has adjusted the revised 1995 aggregate production quotas 
for amphetamine, diphenoxylate, fentanyl, hydromorphone, methadone, 
methadone intermediate (for conversion), morphine and oxycodone (for 
sale) to meet the estimated medical, scientific, research and 
industrial needs of the United States.
    Regarding hydrocodone and methylphenidate, the DEA has decided that 
no adjustments are necessary to meet the 1995 estimated medical, 
scientific, research and industrial needs of the United States.
    The Office of Management and Budget has determined that notices of 
aggregate production quotas are not subject to centralized review under 
Executive Order 12866. This action has been analyzed in accordance with 
the principles and criteria contained in Executive Order 12612, and it 
has been determined that this matter does not have sufficient 
Federalism implications to warrant the preparation of a Federalism 
Assessment.
    The Deputy Administrator hereby certifies that this action will 
have no significant impact upon small entities whose interests must be 
considered under the Regulatory Flexibility Act, 5 U.S.C. 601, et seq. 
The establishment of aggregate production quotas for Schedules I and II 
controlled substances is mandated by law and by international treaty 
obligations. While aggregate production quotas are of primary 
importance to large manufacturers, their 

[[Page 35051]]
impact upon small entities is neither negative nor beneficial. 
Accordingly, the Deputy Administrator has determined that this action 
does not required a regulatory flexibility analysis.
    Therefore, under the authority vested in the Attorney General by 
Section 306 of the Controlled Substances Act of 1970 (21 U.S.C. 826), 
delegated to the Administrator by Section 0.100 of Title 28 of the Code 
of Federal Regulations, and redelegated to the Deputy Administrator of 
the DEA by Section 0.104 of Title 28 of the Code of Federal 
Regulations, the Deputy Administrator hereby orders that the 1995 
revised aggregate production quotas, expressed in grams of anhydrous 
acid or base, be established as follows:

------------------------------------------------------------------------
                                                           Established  
                      Basic class                         revised 1995  
                                                             quotas     
------------------------------------------------------------------------
Schedule I:                                                             
    Acetylmethadol....................................                 7
    Alphacetylmethadol................................                 5
    Aminorex..........................................                 7
    Bufotenine........................................                10
    Cathinone.........................................                 9
    Difenoxin.........................................            14,000
    Dihydromorphine...................................                 5
    2,5-Dimethoxyamphetamine..........................        15,650,000
    Dimethoxyamphetamine..............................                 7
    Ethylamine analog of Phencyclidine................                 5
    N-Ethylamphetamine................................                 9
    Lysergic acid diethylamide........................                56
    Mescaline.........................................                 7
    Methaqualone......................................                 7
    Methcathinone.....................................                14
    4-Methoxyamphetamine..............................                17
    4-Methylaminorex..................................                 2
    3,4-Methylenedioxyamphetamine.....................                17
    3,4-Methylenedioxy-N-ethylamphetamine.............                27
    3,4-Methylenedioxymethamphetamine.................                17
    3-Methylfentanyl..................................                14
    Normethadone......................................                 5
    Normorphine.......................................                 7
    Tetrahydrocannabinols.............................            35,000
    Thiophene Analog of Phencyclidine.................                10
Schedule II:                                                            
    Alfentanil........................................             7,000
    Amobarbital.......................................                15
    Amphetamine.......................................         1,226,000
    Cocaine...........................................           550,000
    Codeine (for sale)................................        67,312,000
    Codeine (for conversion)..........................        16,181,000
    Desoxyephedrine...................................         1,154,000
                                                                        
------------------------------------------------------------------------
  (1,138,000 grams of levo-desoxyephedrine for use in a non-controlled, 
     non-prescription product and 16,000 grams for methamphetamine)     
                                                                        
------------------------------------------------------------------------
    Dextropropoxyphene................................       124,012,000
    Dihydrocodeine....................................           100,000
    Diphenoxylate.....................................           965,000
    Ecogonine (for conversion)........................           650,000
    Ethylmorphine.....................................                10
    Fentanyl..........................................           114,200
    Hydrocodone.......................................         8,474,000
    Hydromorphone.....................................           435,500
    Isomethadone......................................                10
    Levo-alpha-acetylmethadol.........................           200,000
    Levorphanol.......................................             8,000
    Meperidine........................................         9,521,000
    Methadone.........................................         4,388,000
    Methadone (for conv)..............................           364,000
    Methadone Intermediate (for sale).................                 0
    Methadone Int. (for conv).........................         5,533,000
    Methylphenidate...................................        10,410,000
    Morphine (for sale)...............................        11,145,000
    Morphine (for conv)...............................        78,105,000
    Noroxymorphone (for sale).........................            21,000
    Noroxymorphone (for conv).........................         3,500,000
    Opium.............................................         1,304,000
    Oxycodone (for sale)..............................         4,794,000
    Oxycodone (for conv)..............................            25,500
    Oxymorphone.......................................            10,200
    Pentobarbital.....................................        15,706,000

[[Page 35052]]
                                                                        
    Phencyclidine.....................................                72
    Phenylacetone (for conv)..........................         3,528,000
    1-Phenylcyclohexylamine...........................                10
    1-Piperidinocyclohexanecarbonitrile...............                10
    Secobarbital......................................           322,000
    Sufentanil........................................             1,600
    Thebaine..........................................         9,383,000
------------------------------------------------------------------------



    Dated: June 26, 1995.
Stephen H. Greene,
Deputy Administrator.
[FR Doc. 95-16321 Filed 7-3-95; 8:45 am]
BILLING CODE 4410-09-M